Clinical features of patients with myasthenia gravis associated with autoimmune diseases

Eur J Neurol. 2007 Dec;14(12):1403-4. doi: 10.1111/j.1468-1331.2007.01978.x. Epub 2007 Oct 17.

Abstract

We investigated the incidence and clinical features of patients with myasthenia gravis (MG) associated with autoimmune diseases. Associated autoimmune diseases were found in 28 of 142 consecutive Japanese MG patients (19.7%), amongst which Graves' disease (7.7%) and Hashimoto's thyroiditis (4.2%) were predominant. The clinical features of MG patients with Graves' disease were different from those of MG patients without autoimmune diseases in terms of age at onset of MG symptoms (35.5 +/- 4.0 years and 49.0 +/- 1.7 years; P < 0.05), positivity for the anti-acetylcholine receptor antibody (44.4% and 89.8%; P < 0.05), and association with thymic hyperplasia (72.7 and 17.9%; P < 0.05). The therapeutic outcome of MG patients with Graves' disease and that of those without autoimmune diseases were not significantly different. Further studies should be performed to investigate whether MG associated with Graves' disease is a distinct subtype of MG.

MeSH terms

  • Adolescent
  • Adult
  • Age of Onset
  • Aged
  • Aged, 80 and over
  • Autoantibodies / blood
  • Autoantibodies / immunology
  • Autoimmune Diseases / epidemiology*
  • Autoimmune Diseases / immunology
  • Autoimmune Diseases / physiopathology
  • Child
  • Comorbidity
  • Female
  • Graves Disease / epidemiology
  • Graves Disease / immunology
  • Graves Disease / physiopathology
  • Hashimoto Disease / epidemiology
  • Hashimoto Disease / immunology
  • Hashimoto Disease / physiopathology
  • Humans
  • Japan / epidemiology
  • Male
  • Middle Aged
  • Myasthenia Gravis / epidemiology*
  • Myasthenia Gravis / immunology
  • Myasthenia Gravis / physiopathology
  • Prevalence
  • Receptors, Cholinergic / immunology
  • Thymus Hyperplasia / epidemiology
  • Thymus Hyperplasia / immunology
  • Thymus Hyperplasia / physiopathology
  • Treatment Outcome

Substances

  • Autoantibodies
  • Receptors, Cholinergic